Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Cell Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04703686
What this trial is testing

Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy

Who this might be right for
Diffuse Large B-Cell Lymphoma RefractoryRefractory Indolent Adult Non-Hodgkin LymphomaRefractory Transformed B-cell Non-Hodgkin Lymphoma+2 more
The Lymphoma Academic Research Organisation 67
Not applicableEnded earlyNCT00578461
What this trial is testing

T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE

Who this might be right for
LeukemiaCancerLymphoma+2 more
Baylor College of Medicine 26
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07535762
What this trial is testing

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma

Who this might be right for
Peripheral T-Cell Lymphoma (PTCL NOS)Nodal T-follicular Helper Cell LymphomaAnaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative)
Shanghai Jiao Tong University School of Medicine 36
Testing effectiveness (Phase 2)Ended earlyNCT00005982
What this trial is testing

506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma

Who this might be right for
Recurrent Cutaneous T-cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides/Sezary Syndrome
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)UnknownNCT05066958
What this trial is testing

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Who this might be right for
Acute Myeloid LeukemiaHigh Risk Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia, in Relapse+4 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 20
Not applicableStudy completedNCT02652715
What this trial is testing

Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma+29 more
Mayo Clinic 29
Testing effectiveness (Phase 2)Study completedNCT00238433
What this trial is testing

Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
OHSU Knight Cancer Institute 37
Early research (Phase 1)Study completedNCT00348985
What this trial is testing

PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+58 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Looking for participantsNCT04752826
What this trial is testing

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Who this might be right for
Advanced MalignanciesOvarian CancerT-cell Lymphoma+1 more
BioInvent International AB 250
Early research (Phase 1)Study completedNCT02783625
What this trial is testing

Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas

Who this might be right for
LymphomaRelapsed/Refractory T-cell Lymphomas
Memorial Sloan Kettering Cancer Center 114
Early research (Phase 1)Study completedNCT01026415
What this trial is testing

Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)

Who this might be right for
CarcinomasDisease, HodgkinLymphoma, Large-Cell, Anaplastic+2 more
Seagen Inc. 73
Early research (Phase 1)UnknownNCT05900089
What this trial is testing

Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Henan Cancer Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07293403
What this trial is testing

Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas

Who this might be right for
Follicular Helper T-Cell LymphomaPeripheral T-Cell Lymphoma, Not Otherwise Specified
City of Hope Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT00959686
What this trial is testing

Bendamustine in Patients With Refractory or Relapsed T-cell Lymphoma

Who this might be right for
T-cell Lymphoma
French Innovative Leukemia Organisation 45
Testing effectiveness (Phase 2)Ended earlyNCT03743246
What this trial is testing

Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, Non-Hodgkin
Celgene 21
Not applicableLooking for participantsNCT07750886
What this trial is testing

Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)

Who this might be right for
Non-Hodgkin LymphomaT-Cell LymphomaDiffuse Large B-Cell Lymphoma+7 more
Natera, Inc. 200
Early research (Phase 1)Not Yet RecruitingNCT07679919
What this trial is testing

BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic LeukemiaHairy Cell Leukemia+1 more
Luminary Therapeutics 27
Early research (Phase 1)Looking for participantsNCT05312801
What this trial is testing

Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin Lymphoma, B-Cell
Luminary Therapeutics 20
Early research (Phase 1)Study completedNCT00004057
What this trial is testing

Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center 40
Next Page